As of January 6, 2025 here is a list of approved and pending new GLP-1 agonists class of medications that can help manage Type 2 diabetes and obesity: Ozempic (semaglutide) Approved - A weekly injectable GLP-1 receptor agonist that helps regulate blood sugar and suppress appetite, promoting weight loss in addition to managing type 2 diabetes
Yes Akkermansia strengthens the gut barrier, increases SCFA synergy, improves GLP-1 sensitivity, and reduces inflammation
3h,i and Extended Data Fig
Insulin resistance and glucose regulation Insulin resistance is not just a diabetes issue
The initial dosing starts at 0.25 mg per week and is gradually increased at 4-week intervals to 0.5, 1.0, 1.7 mg, and finally to a maximum dose of 2.4 mg per week
Check with your specific pharmacy for pricing details